The relationship between quantitative human epidermal growth factor receptor 2 gene expression by the 21-gene reverse transcriptase polymerase chain reaction assay and adjuvant trastuzumab benefit in Alliance N9831
- Citation:
- Breast Cancer Res vol 17
- Year:
- 2015
- Type:
- Manuscript
- Funding:
- NCTN
- Endpoint:
- Secondary
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- Accepted
- Note:
- 2238 is parent abstract. Also supported by the Breast Cancer Research Foundation and Genentech (35-03)
- Methodological:
- No
- Biospecimen:
- Yes
- SDC:
- Yes
- Book Volume:
- 5
- Parents:
- 963
- Children:
- None
- Pharmas:
- Grants:
- U24CA196171 , U10 CA180821, P50 CA121973, U10-CA025224, P30 CA023108, U10-CA180821, U10 CA180882, U24 CA196171, R01 CA129949, U10-CA180882, U10 CA025224, U10 CA180844
- Corr. Author:
- Authors:
- Edith A. Perez Frederick L. Baehner Steven M. Butler E. Aubrey Thompson Amylou C. Dueck Farid Jamshidian Diana Cherbavaz Carl Yoshizawa Steven Shak Peter A. Kaufman Nancy E. Davidson Julie Gralow Yan W. Asmann Karla V. Ballman
- Networks:
- LAPS-MN026, PR028, VT004
- Study
- NCCTG-N9831
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 3
- Keywords:
- Research Article